ArticleMedicine2026
Identification of anoikis-related subtypes in hepatocellular carcinoma and construction of prognostic model: Construction of prognostic model.
Article in Medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aimed to investigate the distinct subtypes of anoikis in hepatocellular carcinoma (HCC) and their underlying molecular mechanisms, and to construct a prognostic risk model. The gene expression profiles of HCC were downloaded from the cancer genome atlas and gene expression omnibus database, while anoikis-related genes were obtained from the GeneCards database. Unsupervised clustering algorithms were applied based on the expression of differentially expressed anoikis genes to identify related subtypes. Survival curves were used to analyze the differences in survival between subtypes, and the enrichment pathways and immune microenvironment differences were explored. Limma analysis, Cox proportional hazards regression analysis, and Least absolute shrinkage and selection operator regression algorithms were utilized to identify genes affecting the prognosis of subtypes and to construct a prognostic model, while also classifying high and low-risk groups for immune correlation analysis. The study identified 2 subtypes, C1 and C2, which showed significant differences in survival probability, enriched pathways, and immune microenvironment. SFN, BUB1, BSG, and HMOX1 were identified as prognostic genes, and a prognostic model was successfully constructed. There were significant differences in prognosis, expression of prognostic genes, and immune microenvironment between the high-risk and low-risk groups. The identification of different subtypes of anoikis in HCC and the construction of a prognostic model provide new insights and directions for the treatment and prognosis research of HCC.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.